R
Romark Laboratories
Innovative pharmaceutical company developing treatments for viral respiratory infections with a global impact
About Romark Laboratories
Romark Innovative Medicine Research is a pharmaceutical company dedicated to discovering, developing, and delivering new medicines that positively impact lives worldwide. The company has evolved from a small research development firm into a significant player in the pharmaceutical industry, with a strong focus on viral respiratory infections. Romark serves a global market, providing innovative treatments that have been used by over 300 million people. The business model revolves around extensive research and development, leading to the creation of proprietary medications that are then marketed and sold globally. Revenue is generated through the sale of these pharmaceutical products. The company is led by a team of experienced industry veterans and lifelong innovators, ensuring a continuous pipeline of groundbreaking treatments. Romark's core values emphasize innovation, problem-solving, and a commitment to improving global health.
Source: Dealroom company dataAt a glance
- Founded
- 1993
- Headquarters
- Tampa, United States
- Sector
- Health
Knowledge graph
More headlines
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Romark Laboratories on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Romark Laboratories on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.